Skip to content

Omnicell OMCL Allowance for Doubtful Accounts

Allowance for Doubtful Accounts at other companies

Baxter International logo
Baxter InternationalBAX
ICU Medical logo
ICU MedicalICUI
Haemonetics logo
HaemoneticsHAE
Solventum logo
SolventumSOLV
Medline, Inc.
 logo
Medline, Inc. MDLN
CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's allowance for doubtful accounts?
Omnicell (OMCL) reported allowance for doubtful accounts of $7.3M in Q1 2026.
How has Omnicell's allowance for doubtful accounts changed year-over-year?
Omnicell's allowance for doubtful accounts increased by 4.9% year-over-year, from $6.95M to $7.3M.
What is the long-term trend for Omnicell's allowance for doubtful accounts?
Over 5 years (2020 to 2025), Omnicell's allowance for doubtful accounts has grown at a 15.7% compound annual growth rate (CAGR), from $4.29M to $8.87M.